IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
- Vijayaprakash Suppiah
- , Max Moldovan
- , Golo Ahlenstiel
- , Thomas Berg
- , Martin Weltman
- , Maria Lorena Abate
- , Margaret Bassendine
- , Ulrich Spengler
- , Gregory J. Dore
- , Elizabeth Powell
- , Stephen Riordan
- , David Sheridan
- , Antonina Smedile
- , Vincenzo Fragomeli
- , Tobias Müller
- , Melanie Bahlo
- , Graeme J. Stewart
- , David R. Booth
- , Jacob George*
*Corresponding author for this work
- University of Sydney
- University of Melbourne
- University of Bonn
- Charité Universitätsmedizin Berlin
- Nepean Hospital
- University of Turin
- Newcastle University
- St. Vincent's Hospital Sydney
- University of New South Wales
- Princess Alexandra Hospital
- University of Queensland
Research output: Contribution to journal › Article › peer-review